x NoneEntity Type
0001372514
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 EYEGATE PHARMACEUTICALS INC
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 EYEGATE PHARMACEUTICALS INC 
Street Address 1Street Address 2
 271 WAVERLEY OAKS ROAD, SUITE 108 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 WALTHAM MASSACHUSETTS 02452 781-788-9043 



3. Related Persons
Last NameFirst NameMiddle Name
StremBrian
Street Address 1Street Address 2
271 Waverley Oaks Road, Suite 108
CityState/Province/CountryZIP/Postal Code
WalthamMASSACHUSETTS02452
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 President and Chief Executive Officer

Last NameFirst NameMiddle Name
RomanoSarah
Street Address 1Street Address 2
271 Waverley Oaks Road, Suite 108
CityState/Province/CountryZIP/Postal Code
WalthamMASSACHUSETTS02452
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 Chief Financial Officer

Last NameFirst NameMiddle Name
FromStephen
Street Address 1Street Address 2
271 Waverley Oaks Road, Suite 108
CityState/Province/CountryZIP/Postal Code
WalthamMASSACHUSETTS02452
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 Executive Chairman

Last NameFirst NameMiddle Name
ChaneyPaul
Street Address 1Street Address 2
271 Waverley Oaks Road, Suite 108
CityState/Province/CountryZIP/Postal Code
WalthamMASSACHUSETTS02452
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
ShapiroAron
Street Address 1Street Address 2
271 Waverley Oaks Road, Suite 108
CityState/Province/CountryZIP/Postal Code
WalthamMASSACHUSETTS02452
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
GayronKenneth
Street Address 1Street Address 2
271 Waverley Oaks Road, Suite 108
CityState/Province/CountryZIP/Postal Code
WalthamMASSACHUSETTS02452
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
TylePraveen
Street Address 1Street Address 2
271 Waverley Oaks Road, Suite 108
CityState/Province/CountryZIP/Postal Code
WalthamMASSACHUSETTS02452
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2021-08-09 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests o Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 H.C. Wainwright & Co., LLC 375
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 430 PARK AVENUE  
City State/Province/CountryZIP/Postal Code
 NEW YORK NEW YORK 10022
State(s) of Solicitation o All States o Foreign/Non-US
 FLORIDA
 ILLINOIS
 NEVADA
 NEW JERSEY
 NEW YORK
 TEXAS
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 10750013 USD o Indefinite
Total Amount Sold $ 10750013 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
 This amount includes proceeds from the sale of common shares pursuant to a separate registered direct offering, as well as the warrants covered by this filing. The amount does not include proceeds from the exercise of warrants.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 14


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 860001 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
 H.C. Wainwright & Co., LLC also received warrants to purchase 233,442 warrants of common stock. The compensation also covers the sale of common stock in the concurrent registered direct offering, as well as the warrants covered by this filing.


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
AB Corporate Bond ETF (NASDAQ:EYEG)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more AB Corporate Bond ETF Charts.
AB Corporate Bond ETF (NASDAQ:EYEG)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more AB Corporate Bond ETF Charts.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EYEG Message Board. Create One! See More Posts on EYEG Message Board See More Message Board Posts

Eyegate Pharmaceuticals Inc News

Loading Messages....

More Eyegate Pharmaceuticals Inc News Articles